D. Ware Branch
Rating: 4.4 of 5
( out of 43 reviews )

D. Ware Branch, MD

Languages spoken: English

Clinical Locations

Primary Location

South Jordan Health Center

Women's Health Services
5126 West Daybreak Parkway
South Jordan , UT 84009
801-213-2995
Get Directions

University of Utah Hospital

University Maternal Fetal Medicine, Area E
50 N Medical Dr
Salt Lake City , UT 84132
801-213-2995
Get Directions

Sugar House Health Center

Women's Health Services
1280 E. Stringham Avenue
Salt Lake City , UT 84106
801-213-2995
Get Directions

  • Dr. Ware Branch has a passion for helping those who face complex pregnancy challenges and cares for his patients experiencing high-risk pregnancies. As a specialist in maternal-fetal medicine, Dr. Branch specializes in managing various conditions, including recurrent miscarriage, genetics and fetal diagnosis, placenta accreta, and stillbirth. He is committed to achieving the best possible outcomes for his patients and is here to support you and your family every step of the way through your pregnancy journey.

    Dr. Branch is currently accepting new patients. Please call to schedule an appointment or for more information.

    Dr. Branch has been dedicated to high-risk pregnancies since 1985, when he completed his fellowship in maternal-fetal medicine at the University of Utah and completed specialty training.

    He now leads the fellowship program, passing on his knowledge and experience to the next generation of doctors. He is also a professor of obstetrics and gynecology at the Spencer Fox Eccles School of Medicine at the University of Utah and serves as the medical director of the women and newborn clinical program for the urban central region of Intermountain Health.

    Dr. Branch is internationally recognized for his research and expertise in managing conditions like antiphospholipid syndrome (APS), thrombotic disorders during pregnancy, and recurrent pregnancy loss.

    Specialties

    Patient Rating

    Rating: 4.4 out of 5
    4.4 /5
    ( out of 43 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    SOUTH JORDAN HEALTH CENTER
    Rating: 5 out of 5

    I appreciated Dr Branch's approach to my care because, while direct, he was also friendly and respectful and really took the time to get to know me. Other doctors made judgements based off of appearances, but he digs deeper to really learn about his patients to offer the best care possible. I've only had one visit, but I'm confident Dr Branch will offer the care I've been looking for.

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    Dr Branch is absolutely phenomenal. We have finally found a doctor who genuinely cares.

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    Dr. Ware Branch was wonderful to work with. He had a good grasp on my health history, and took the time to explain all of the different options I had. He made sure that I understood what he was saying. He was very encouraging and kind.

    SOUTH JORDAN HEALTH CENTER
    Rating: 1 out of 5

    I did NOT like my experience. I seen Dr. Branch while my usual obstetrician was out of town. Dr. Branch made me feel belittled and dumb throughout my appointment. He did not have a good bedside manner, and his attitude was poor. As a first time mom, this was a terrible experience. He did not address any of my questions or concerns. This is especially concerning since I am a high risk pregnancy, and had concerning issues I wanted to address. He deflected my questions and turned them into talks about diet and exercise. I had to message my usual Doctor to get information from my appointment. I didn't even know I had been diagnosed with gestational hypertension until messaging my doctor for clarification. I will NOT be seeing Dr. Branch again, and I do not recommend him to others. His dismissive attitude should not be working with pregnant women, and he should probably retire.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    This was my first visit with Dr. Branch. I am so excited to have him as my Dr for this pregnancy. He listened to me and I felt supported and heard.

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    Dr. Branch and his student were great- they were clear in disseminating information, they answered all of our questions and spent time with us to make sure we had all the information we needed.

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    He seemed very interested in understanding my pregnancy history so I can have a successful pregnancy.

    SOUTH JORDAN HEALTH CENTER
    Rating: 5 out of 5

    Dr.Branch really cares about your success and wants the best for you! He's really great!

    SOUTH JORDAN HEALTH CENTER
    Rating: 5 out of 5

    Dr Branch is very nice and caring. He truely was concern for us.

  • Dr. Ware Branch has a passion for helping those who face complex pregnancy challenges and cares for his patients experiencing high-risk pregnancies. As a specialist in maternal-fetal medicine, Dr. Branch specializes in managing various conditions, including recurrent miscarriage, genetics and fetal diagnosis, placenta accreta, and stillbirth. He is committed to achieving the best possible outcomes for his patients and is here to support you and your family every step of the way through your pregnancy journey.

    Dr. Branch is currently accepting new patients. Please call to schedule an appointment or for more information.

    Dr. Branch has been dedicated to high-risk pregnancies since 1985, when he completed his fellowship in maternal-fetal medicine at the University of Utah and completed specialty training.

    He now leads the fellowship program, passing on his knowledge and experience to the next generation of doctors. He is also a professor of obstetrics and gynecology at the Spencer Fox Eccles School of Medicine at the University of Utah and serves as the medical director of the women and newborn clinical program for the urban central region of Intermountain Health.

    Dr. Branch is internationally recognized for his research and expertise in managing conditions like antiphospholipid syndrome (APS), thrombotic disorders during pregnancy, and recurrent pregnancy loss.

    Board Certification and Academic Information

    Academic Departments Obstetrics & Gynecology -Professor
    Academic Divisions Maternal Fetal Medicine

    Education history

    Undergraduate Biology - University of Richmond B.S.
    Professional Medical Medicine - Medical College of Virginia M.D.
    Internship OB/GYN - Medical College of Virginia Hosp. Intern
    Residency OB/GYN - Medical College of Virginia Hospital Resident
    Fellowship Maternal/Fetal Medicine - University of Utah School of Medicine Fellow

    Selected Publications

    Journal Article

    1. Zuo Y, Navaz S, Tsodikov A, Kmetova K, Kluge L, Ambati A, Hoy CK, Yalavarthi S, de Andrade D, Tektonidou MG, Sciascia S, Pengo V, Ruiz-Irastorza G, Belmont HM, Gerosa M, Fortin PR, de Jesus GR, Branch DW, Andreoli L, Rodriguez-Almaraz E, Petri M, Cervera R, Willis R, Karp DR, Li QZ, Cohen H, Bertolaccini ML, Erkan D, Knight JS, Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networkin (2023). Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository. Arthritis & rheumatology (Hoboken, N.J.), 75(8), 1407-1414. (Read full publication)
    2. Branch DW, VanBuren JM, Porter TF, Holmgren C, Holubkov R, Page K, Burchard J, Lam GK, Esplin M (2023). Prediction and Prevention of Preterm Birth: A Prospective, Randomized Intervention Trial. American journal of perinatology, 40(10), 1071-1080. (Read full publication)
    3. Balbi GGM, Ahmadzadeh Y, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Lopez-Pedrera C, Fortin PR, Wahl D, Gerosa M, de Jesús GR, Ji L, Atsumi T, Efthymiou M, Branch DW, Nalli C, Almaraz ER, Petri M, Cervera R, Knight JS, Artim-Esen B, Willis R, Bertolaccini ML, Cohen H, Roubey R, Erkan D, Andrade D, AntiPhospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (APS ACTION (2023). Damage measured by damage index for antiphosphlipid syndrome in antiphospholipid antibody-positive patients included in APS ACTION Registry. Rheumatology (Oxford, England), (Read full publication)
    4. Gkrouzman E, Willis R, Andrade D, Tektonidou MG, Pengo V, Ruiz-Irastorza G, Belmont HM, Fortin PR, Gerosa M, Signorelli F, Atsumi T, Branch DW, Nalli C, Rodriguez-Almaraz E, Petri MA, Cervera R, Knight JS, Efthymiou M, Cohen H, Bertolaccini ML, Erkan D, Roubey R, APS ACTIO (2023). Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study. Laboratory investigation; a journal of technical methods and pathology, 103(6), 100147. (Read full publication)
    5. Chighizola CB, Pregnolato F, Andrade D, Tektonidou M, Pengo V, Ruiz-Irastorza G, Belmont HM, Gerosa M, Fortin P, Branch DW, Andreoli L, Petri MA, Cervera R, Knight JS, Willis R, Efthymiou M, Cohen H, Erkan D, Bertolaccini ML, Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION (2023). Fluctuation of Anti-Domain 1 and Anti-ß(2) -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies. Arthritis & rheumatology (Hoboken, N.J.), 75(6), 984-995. (Read full publication)
    6. Einerson BD, Kennedy A, Silver RM, Branch DW, Comstock J, Woodward P (2023). Ultrasonography of the Explanted Uterus in Placenta Accreta Spectrum: Correlation With Intraoperative Findings and Gross Pathology. Obstetrics and gynecology, 141(3), 544-554. (Read full publication)
    7. Dude AM, Smid MC, Branch DW, West J, Meeks H, Yu Z, Fraser A, Smith K, Reddy (2023). Interpregnancy Body Mass Index Change and Offspring Mortality Risk following the Second Pregnancy. American journal of perinatology, 40(4), 387-393. (Read full publication)
    8. Workalemahu T, Avery C, Lopez S, Blue NR, Wallace A, Quinlan AR, Coon H, Warner D, Varner MW, Branch DW, Jorde LB, Silver R (2023). Whole-genome sequencing analysis in families with recurrent pregnancy loss: A pilot study. PloS one, 18(2), e0281934. (Read full publication)
    9. Mehta B, Jannat-Khah D, Glaser KK, Luo Y, Sammaritano LR, Branch DW, Goodman SM, Lockshin M, Wang F, Ibrahim S, Salmon J (2023). Fetal and maternal morbidity in pregnant patients with Lupus: a 10-year US nationwide analysis. RMD open, 9(1), (Read full publication)
    10. Lim MY, Abou-Ismail MY, Branch D (2023). Differentiating and Managing Rare Thrombotic Microangiopathies During Pregnancy and Postpartum. Obstetrics and gynecology, 141(1), 85-108. (Read full publication)
    11. Young A, Lim MY, Sanders J, Branch DW, Simonsen S (2023). Pregnancy and childbirth in women with bleeding disorders: A retrospective cohort study. Haemophilia, 29(1), 240-247. (Read full publication)
    12. Scaglione MA, Allshouse AA, Canfield DR, Mclaughlin HD, Bruno AM, Hammad IA, Branch DW, Maurer KA, Dood RL, Debbink MP, Silver RM, Einerson B (2022). Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstetrics and gynecology, 140(5), 806-811. (Read full publication)
    13. Bruno AM, Allshouse AA, Campbell HM, Branch DW, Lim MY, Silver RM, Metz T (2022). Weight-Based Compared With Fixed-Dose Enoxaparin Prophylaxis After Cesarean Delivery: A Randomized Controlled Trial. Obstetrics and gynecology, 140(4), 575-583. (Read full publication)
    14. Erton ZB, Sevim E, de Jesús GR, Cervera R, Ji L, Pengo V, Ugarte A, Andrade D, Andreoli L, Atsumi T, Fortin PR, Gerosa M, Zuo Y, Petri M, Sciascia S, Tektonidou MG, Aguirre-Zamorano MA, Branch DW, Erkan D, APS ACTIO (2022). Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry'). Lupus science & medicine, 9(1), (Read full publication)
    15. Woller SC, Stevens SM, Kaplan D, Wang TF, Branch DW, Groat D, Wilson EL, Armbruster B, Aston VT, Lloyd JF, Rondina MT, Elliott C (2022). Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. Blood advances, 6(6), 1661-1670. (Read full publication)
    16. Givens M, Einerson BD, Allshouse AA, Bruno AM, Hammad I, Debbink MP, Branch DW, Silver R (2022). Trends in Unplanned Peripartum Hysterectomy in the United States, 2009-2020. Obstetrics and gynecology, 139(3), 449-451. (Read full publication)
    17. Sevim E, Zisa D, Andrade D, Sciascia S, Pengo V, Tektonidou MG, Ugarte A, Gerosa M, Belmont HM, Zamorano MAA, Fortin PR, Ji L, Efthymiou M, Cohen H, Branch DW, de Jesus GR, Andreoli L, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Roubey R, Bertolaccini ML, Erkan D, Barbhaiya M, APS ACTION Investigator (2022). Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository. Arthritis care & research, 74(2), 324-335. (Read full publication)
    18. Arslan E, Einerson BD, Zhang J, Zhang J, Branch D (2021). The Effect of "Off Hours" on Maternal and Perinatal Outcomes in a Diverse U.S. Cohort. American journal of perinatology, 41(1), 89-97. (Read full publication)
    19. de Azevedo Lopes E, Balbi GGM, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Gerosa M, Fortin PR, Lopez-Pedrera C, Ji L, Cohen H, de Jesús GR, Branch DW, Nalli C, Petri M, Rodriguez E, Kello N, Ríos-Garcés R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Erkan D, Andrade D, APS ACTIO (2021). Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository. Advances in rheumatology (London, England), 61(1), 64. (Read full publication)
    20. Gkrouzman E, Sevim E, Finik J, Andrade D, Pengo V, Sciascia S, Tektonidou MG, Ugarte A, Chighizola CB, Belmont HM, Lopez-Pedrera C, Ji L, Fortin P, Efthymiou M, de Jesus GR, Branch DW, Nalli C, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Cohen H, Rand J, Erkan D, APS ACTION (2021). Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository. The Journal of rheumatology, 48(4), 541-547. (Read full publication)
    21. Carey AZ, Blue NR, Varner MW, Page JM, Chaiyakunapruk N, Quinlan AR, Branch DW, Silver RM, Workalemahu (2021). A systematic review to guide future efforts in the determination of genetic causes of pregnancy loss. Frontiers in reproductive health, 3, (Read full publication)
    22. Paidas MJ, Tita ATN, Macones GA, Saade GA, Ehrenkranz RA, Triche EW, Streisand JB, Lam GK, Magann EF, Lewis DF, Dombrowski MP, Werner EF, Branch DW, Habli MA, Grotegut CA, Silver RM, Longo SA, Amon E, Cleary KL, How HY, Novotny SR, Grobman WA, Whiteman VE, Wing DA, Scifres CM, Sibai B (2020). Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia. American journal of obstetrics and gynecology, 223(5), 739.e1-739.e13. (Read full publication)
    23. Zuily S, Clerc-Urmès I, Bauman C, Andrade D, Sciascia S, Pengo V, Tektonidou MG, Ugarte A, Gerosa M, Michael Belmont H, Zamorano MAA, Fortin P, Ji L, Efthymiou M, Cohen H, Branch DW, Jesus GR, Nalli C, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Vega J, Wahl D, Erkan D, APS ACTION Investigator (2020). Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry. Lupus, 29(11), 1353-1363. (Read full publication)
    24. Yelnik CM, Erton ZB, Drumez E, Cheildze D, de Andrade D, Clarke A, Tektonidou MG, Sciascia S, Pardos-Gea J, Pengo V, Ruiz-Irastorza G, Belmont HM, Pedrera CL, Fortin PR, Wahl D, Gerosa M, Kello N, Signorelli F, Atsumi T, Ji L, Efthymiou M, Branch DW, Nalli C, Rodriguez-Almaraz E, Petri M, Cervera R, Shi H, Zuo Y, Artim-Esen B, Pons-Estel G, Willis R, Barber MRW, Skeith L, Bertolaccini ML, Cohen H, Roubey R, Erkan (2024). Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry"). Seminars in arthritis and rheumatism, 65, 152347. (Read full publication)
    25. Lim MY, Rodgers GM, Branch DW, Simonsen S (2024). Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: Outcomes at a single-institution cohort study. Haemophilia, 30(2), 470-477. (Read full publication)
    26. Branch DW, Lim M (2024). How I diagnose and treat antiphospholipid syndrome in pregnancy. Blood, 143(9), 757-768. (Read full publication)
    27. Zhu H, Lu D, Branch DW, Troendle J, Tang Y, Bernitz S, Zamora J, Betran AP, Zhou Y, Zhang (2024). Oxytocin is not associated with postpartum hemorrhage in labor augmentation in a retrospective cohort study in the United States. American journal of obstetrics and gynecology, 230(2), 247.e1-247.e9. (Read full publication)
    28. Bruno AM, Allshouse AA, Benson AE, Yost CC, Metz TD, Varner MW, Silver RM, Branch D (2023). Thrombotic Markers in Pregnant Patients with and without SARS-CoV-2 Infection. American journal of perinatology, 41(S 01), e3202-e3209. (Read full publication)
    29. Parks AL, Fazili M, Aston V, Porter TF, Branch DW, Woller SC, Snow GL, Stevens S (2023). Excluding pregnancy-associated deep vein thrombosis with whole-leg ultrasound. Research and practice in thrombosis and haemostasis, 7(7), 102202. (Read full publication)
    30. Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont HM, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jesús G, Delluc A, Desai S, Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-García A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D, ACR/EULAR APS Classification Criteria Collaborator (2023). 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Annals of the rheumatic diseases, 82(10), 1258-1270. (Read full publication)
    31. Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont HM, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jesus G, Delluc A, Desai S, De Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-Garcia A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D, ACR/EULAR APS Classification Criteria Collaborator (2023). The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis & rheumatology (Hoboken, N.J.), 75(10), 1687-1702. (Read full publication)

    Review

    1. Welsch S, Branch D (1997). Antiphospholipid syndrome in pregnancy. Obstetric concerns and treatment. Rheumatic diseases clinics of North America, 23(1), 71-84. (Read full publication)
    2. Knight JS, Branch DW, Ortel T (2023). Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ (Clinical research ed.), 380, e069717. (Read full publication)
    3. Barbhaiya M, Zuily S, Ahmadzadeh Y, Amigo MC, Avcin T, Bertolaccini ML, Branch DW, de Jesus G, Devreese KMJ, Frances C, Garcia D, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Seshan SV, Tektonidou M, Wahl D, Willis R, Naden R, Costenbader K, Erkan D, New APS Classification Criteria Collaborator (2021). Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria. Arthritis care & research, 73(10), 1490-1501. (Read full publication)
    4. de Jesús GR, Benson AE, Chighizola CB, Sciascia S, Branch D (2020). 16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome. Lupus, 29(12), 1601-1615. (Read full publication)
    5. Chighizola CB, Willis R, Maioli G, Sciascia S, Andreoli L, Amengual O, Radin M, Gerosa M, Atsumi T, de Jesus G, Trespidi L, Branch DW, Caporali R, Andrade D, Roubey R, Petri M, Bertolaccini M (2024). Deciphering the clinical significance of longitudinal antiphospholipid antibody titers. Autoimmunity reviews, 23(3), 103510. (Read full publication)

    Commentary

    1. Einerson BD, Comstock J, Silver RM, Branch DW, Woodward PJ, Kennedy (2020). In Reply. Obstetrics and gynecology, 136(3), 632. (Read full publication)
    2. Shainker SA, Silver RM, Modest AM, Hacker MR, Hecht JL, Salahuddin S, Dillon ST, Ciampa EJ, D'Alton ME, Otu HH, Abuhamad AZ, Einerson BD, Branch DW, Wylie BJ, Libermann TA, Karumanchi S (2020). Placenta accreta spectrum: biomarker discovery using plasma proteomics. American journal of obstetrics and gynecology, 223(3), 433.e1-433.e14. (Read full publication)
    3. Einerson BD, Nelson RE, Sandoval G, Esplin MS, Branch DW, Metz TD, Silver RM, Grobman WA, Reddy UM, Varner M, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Networ (2020). Cost of Elective Labor Induction Compared With Expectant Management in Nulliparous Women. Obstetrics and gynecology, 136(1), 19-25. (Read full publication)
    4. Einerson BD, Comstock J, Silver RM, Branch DW, Woodward PJ, Kennedy (2020). Placenta Accreta Spectrum Disorder: Uterine Dehiscence, Not Placental Invasion. Obstetrics and gynecology, 135(5), 1104-1111. (Read full publication)
    5. Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'Anci K (2020). 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis & rheumatology (Hoboken, N.J.), 72(4), 529-556. (Read full publication)
    6. Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'Anci K (2020). 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis care & research, 72(4), 461-488. (Read full publication)
    7. Arslan E, Branch D (2020). Antiphospholipid syndrome: Diagnosis and management in the obstetric patient. Best practice & research. Clinical obstetrics & gynaecology, 64, 31-40. (Read full publication)
    8. Davis-Porada J, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Sawitzke A, Merrill JT, Buyon JP, Salmon J (2020). Low frequency of flares during pregnancy and post-partum in stable lupus patients. Arthritis research & therapy, 22(1), 52. (Read full publication)
    9. Branch D (2019). What's new in obstetric antiphospholipid syndrome. Hematology. American Society of Hematology. Education Program, 2019(1), 421-425. (Read full publication)
    10. Odendaal J, Quenby S, Sammaritano L, Macklon N, Branch DW, Rosenwaks (2019). Immunologic and rheumatologic causes and treatment of recurrent pregnancy loss: what is the evidence?. Fertility and sterility, 112(6), 1002-1012. (Read full publication)
    11. Efthymiou M, Mackie IJ, Lane PJ, Andrade D, Willis R, Erkan D, Sciascia S, Krillis S, Bison E, Borges Galhardo Vendramini M, Romay-Penabad Z, Qi M, Tektonidou M, Ugarte A, Chighizola C, Belmont HM, Aguirre MA, Ji L, Branch DW, de Jesus G, Fortin PR, Andreoli L, Petri M, Cervera R, Rodriguez E, Knight JS, Atsumi T, Vega J, Sevim E, Bertolaccini ML, Pengo V, Cohen H, APS ACTIO (2019). Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository. Journal of thrombosis and haemostasis, 17(12), 2069-2080. (Read full publication)
    12. Radin M, Sciascia S, Erkan D, Pengo V, Tektonidou MG, Ugarte A, Meroni P, Ji L, Belmont HM, Cohen H, Ramires de Jesús G, Branch DW, Fortin PR, Andreoli L, Petri M, Rodriguez E, Rodriguez-Pinto I, Knight JS, Atsumi T, Willis R, Gonzalez E, Lopez-Pedrera R, Rossi Gandara AP, Borges Gualhardo Vendramini M, Banzato A, Sevim E, Barbhaiya M, Efthymiou M, Mackie I, Bertolaccini ML, Andrade D, APS ACTIO (2019). The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort. Seminars in arthritis and rheumatism, 49(3), 464-468. (Read full publication)
    13. Hong S, Banchereau R, Maslow BL, Guerra MM, Cardenas J, Baisch J, Branch DW, Porter TF, Sawitzke A, Laskin CA, Buyon JP, Merrill J, Sammaritano LR, Petri M, Gatewood E, Cepika AM, Ohouo M, Obermoser G, Anguiano E, Kim TW, Nulsen J, Nehar-Belaid D, Blankenship D, Turner J, Banchereau J, Salmon JE, Pascual (2019). Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy. The Journal of experimental medicine, 216(5), 1154-1169. (Read full publication)
    14. de Jesús GR, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, Pengo V, Ji L, Meroni PL, Ugarte A, Cohen H, Branch DW, Andreoli L, Belmont HM, Fortin PR, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Nascimento IS, Rosa R, Erkan D, Levy RA, APS ACTIO (2019). Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study. BJOG, 126(5), 656-661. (Read full publication)
    15. Sciascia S, Willis R, Pengo V, Krilis S, Andrade D, Tektonidou MG, Ugarte A, Chighizola C, Branch DW, Levy RA, Nalli C, Fortin PR, Petri M, Rodriguez E, Rodriguez-Pinto I, Atsumi T, Nascimento I, Rosa R, Banzato A, Erkan D, Cohen H, Efthymiou M, Mackie I, Bertolaccini ML, APS ACTIO (2019). The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis. Thrombosis research, 175, 32-36. (Read full publication)
    16. Einerson BD, Branch D (2018). Surgical Management of Placenta Accreta Spectrum. Clinical obstetrics and gynecology, 61(4), 774-782. (Read full publication)
    17. Zhang L, Troendle J, Branch DW, Hoffman M, Yu J, Zhou L, Duan T, Zhang (2018). The expected labor progression after labor augmentation with oxytocin: A retrospective cohort study. PloS one, 13(10), e0205735. (Read full publication)
    18. Tebo AE, Willis R, Jaskowski TD, Guerra M, Pierangeli SS, Salmon J, Petri M, Branch D (2016). Clinical significance and correlations between anti-ß2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus. Clinica chimica acta; international journal of clinical chemistry, 460, 107-13. (Read full publication)

    Letter

    1. Bruno AM, Allshouse AA, Einerson BD, Campbell HM, Branch DW, Silver RM, Metz T (2022). Trends in postpartum venous thromboembolism and chemical prophylaxis among insured US patients. American journal of obstetrics & gynecology MFM, 4(4), 100620. (Read full publication)
    2. Harris EN, Goldsmith G, Pierangeli S, Gharavi A, Branch (1995). Phospholipid binding antibodies warrant continued investigation. Blood, 85(8), 2276-7. (Read full publication)
    3. Barbhaiya M, Zuily S, de Jesus G, Branch DW, Erkan (2024). Reply. Arthritis & rheumatology (Hoboken, N.J.), (Read full publication)

  • News & Podcasts

    News